Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Bancroft Charles A
Relationship:   Director
City:   New York
State:   NY
   
Insider Summary:
  
   
Companies Owned :   3    
Direct Shares   168,937    

Indirect Shares

  300,000      
Direct Value   $6,416,008    

Indirect Value

  $12,681,000      
Total Shares   468,937      
Total Value   $19,097,008      


Bristol-Myers Squibb Co
 $5,813,562 Colgate Palmolive Co
 $519,152 Kodiak Sciences Inc.
 $83,293 Bristol-Myers Squibb Co
 $5,813,562 Colgate Palmolive Co
 $519,152 Kodiak Sciences Inc.
 $83,293
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    0    

     Stock price went up :

    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Bristol-Myers Squibb Co BMY EVP, Head of Integration 2020-03-10 137,534 2020-03-10 300,000    Premium*  
            Colgate Palmolive Co CL Director 2018-05-14 5,455 2017-05-15 0    Premium*  
            Kodiak Sciences Inc. KOD Director 2020-04-02 25,948 0    Premium*  
* Premium Members only  

Records found :    117         Free Registration Required For Full Results.    Limit: 25

Download
  Page 2 of 5
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2012-03-02 4 A $0.00 $0 D/D 1,813 59,924 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2012-03-03 4 D $32.59 $29,494 D/D (905) 58,790 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2012-03-03 4 OE $0.00 $0 D/D 2,487 59,695 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2012-03-04 4 OE $0.00 $0 D/D 2,052 60,842 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2012-03-04 4 D $32.59 $24,312 D/D (746) 60,096 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2012-03-06 4 D $32.33 $149,559 D/D (4,626) 66,795 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2012-03-06 4 OE $0.00 $0 D/D 11,325 71,421 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       •      –    2012-12-17 4 OE $23.14 $1,191,115 D/D 47,125 113,920 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       •      –    2012-12-17 4 S $32.77 $1,403,998 D/D (42,844) 71,076 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       •      –    2013-03-03 4 OE $0.00 $0 D/D 2,487 73,563 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       •      –    2013-03-03 4 D $37.15 $28,123 D/D (757) 72,806 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       •      –    2013-03-07 4 D $37.53 $1,179,530 D/D (31,429) 119,015 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       •      –    2013-03-07 4 A $0.00 $0 D/D 8,096 150,444 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       •      –    2013-03-07 4 OE $0.00 $0 D/D 69,542 142,348 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       •      –    2013-05-28 4 S $48.68 $1,217,000 D/D (25,000) 94,015 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2014-02-14 4 OE $22.73 $870,038 D/D 36,251 130,266 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2014-02-14 4 S $54.35 $2,878,285 D/D (52,963) 77,303 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2014-03-03 4 OE $0.00 $0 D/D 121,014 199,850 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2014-03-03 4 D $53.49 $3,285,302 D/D (61,419) 152,303 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2014-03-03 4 A $0.00 $0 D/D 15,405 103,018 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2014-03-06 4 OE $0.00 $0 D/D 7,323 159,626 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2014-03-06 4 A $0.00 $0 D/D 4,972 164,598 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2014-03-06 4 D $55.56 $307,580 D/D (5,536) 159,062 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2014-03-10 4 A $0.00 $0 D/D 2,909 168,381 0 -
BMY Bristol-Myers Squibb Co EVP & Chief Financial Officer   •       –      –    2014-03-10 4 OE $0.00 $0 D/D 6,410 165,472 0 -

  117  Records found
  1   2  3   4   5      
  Page 2 of 5  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed